Full text
Earnings transcript
Read the complete earnings call transcript.
AEHR
Aehr Test Systems
$93.49
2.94
(3.25%)
| Exchange: | NASDAQ |
| Market Cap: | 3.05B |
| Shares Outstanding: | 4.297M |
Delayed data
About The Company
| Sector: | TechnologyView sector performance | |||||
| Industry: | SemiconductorsView industry performance | |||||
| CEO: | Gayn Erickson | |||||
| Full Time Employees: | 138 | |||||
| Address: |
| |||||
| Website: | https://www.aehr.com |
Aehr Test Systems, founded in 1977 and based in Fremont, California, specializes in the global provision of advanced burn-in and test systems for integrated circuits, encompassing logic, optical, and memory devices. Its extensive product lineup includes the ABTS and FOX-P families of test and burn-in solutions, complemented by specialized components such as the FOX WaferPak Aligner, FOX-XP WaferPak Contactor, FOX DiePak Carrier, and FOX DiePak Loader. The ABTS system is specifically designed for both production and qualification assessments of packaged parts, covering a range of lower and higher power logic devices, as well as various memory types. For more complex integrated circuits like memories, digital signal processors, microprocessors, microcontrollers, systems-on-a-chip, and integrated optical devices, the FOX-XP and FOX-NP systems facilitate burn-in and functional testing at both the wafer and individual die/module levels. Aehr’s FOX-CP system offers a compact, single-wafer solution for verifying the reliability of logic, memory, and photonic devices. A distinguishing offering, the WaferPak Contactor, features an exclusive full-wafer probe card, accommodating wafers up to 300mm, which enables semiconductor manufacturers to conduct comprehensive wafer-level testing and burn-in on Aehr’s FOX platforms. Furthermore, the DiePak Carrier provides a reusable, temporary packaging medium, empowering IC manufacturers to complete final testing and burn-in processes for bare die and modules.
Click to read more…
Revenue Segmentation
AEHR full analysis
Hey everyone, welcome back to the channel where we break down stocks with real data and straight talk. Today we're diving deep into Aehr Test Systems, ticker AEHR, a company that's been making waves in the semiconductor test space. Over the past year this name has delivered more than five hundred percent gains, yet the latest quarter shows both explosive backlog growth and a clear earnings reset that investors need to understand. Aehr Test Systems, founded back in 1977 and…
EPS
Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.
Earnings Call
AI summary
Key takeaways
Short, structured highlights from the call so you can focus on what matters.
Log in to continue
Log in to read the full transcript and AI-generated earnings summaries.
Login — it's freeIncome Statement
| Year | 2024 | 2025 | 2026 |
|---|---|---|---|
| Revenue | 66,218 | 58,968 | 50,001 |
| Gross Profit | 32,543 | 23,933 | 17,651 |
| EBITDA | 13,821 | -903 | -11,736 |
| Operating Income | 10,078 | -4,313 | -14,149 |
| Net Income | 33,156 | -3,910 | -7,126 |
(* All numbers are in thousands)
Balance Sheet
| Year | 2024 | 2025 | 2026 |
|---|---|---|---|
| Total Assets | 127,912 | 148,508 | 246,694 |
| Total Liabilities | 16,319 | 25,637 | 27,183 |
| Total Stockholders Equity | 111,593 | 122,871 | 219,511 |
| Total Debt | 6,197 | 10,830 | 9,882 |
| Cash and Cash Equivalents | 49,159 | 24,529 | 116,358 |
(* All numbers are in thousands)
Cash Flow Statement
| Year | 2024 | 2025 | 2026 |
|---|---|---|---|
| Operating Cash Flow | 1,756 | -7,400 | -3,310 |
| Capital Expenditure | -749 | -4,992 | -2,066 |
| Free Cash Flow | 1,007 | -12,392 | -5,376 |
| Net Income | 33,156 | -3,910 | -7,126 |
| Net Change in Cash | 19,105 | -22,829 | 90,028 |
(* All numbers are in thousands)
Analyst Estimates
| Fiscal Year | 2031 | Research Access | Research Access | Research Access | Research Access |
|---|---|---|---|---|---|
| Estimated Revenue (Low) | 282,822.194 | Research Access | Research Access | Research Access | Research Access |
| Estimated Revenue (High) | 293,950.205 | Research Access | Research Access | Research Access | Research Access |
| Estimated Revenue (Avg) | 288,100 | Research Access | Research Access | Research Access | Research Access |
| Estimated Ebitda (Low) | 60,831.836 | Research Access | Research Access | Research Access | Research Access |
| Estimated Ebitda (High) | 63,652.447 | Research Access | Research Access | Research Access | Research Access |
| Estimated Ebitda (Avg) | 62,169.634 | Research Access | Research Access | Research Access | Research Access |
| Estimated Net Income (Low) | 49,398.559 | Research Access | Research Access | Research Access | Research Access |
| Estimated Net Income (High) | 51,939.793 | Research Access | Research Access | Research Access | Research Access |
| Estimated Net Income (Avg) | 50,603.851 | Research Access | Research Access | Research Access | Research Access |
| Estimated SGA Expense (Low) | 72,312.377 | Research Access | Research Access | Research Access | Research Access |
| Estimated SGA Expense (High) | 75,157.603 | Research Access | Research Access | Research Access | Research Access |
| Estimated SGA Expense (Avg) | 73,661.814 | Research Access | Research Access | Research Access | Research Access |
| Estimated EPS (Avg) | 1.650 | Research Access | Research Access | Research Access | Research Access |
| Estimated EPS (High) | 1.690 | Research Access | Research Access | Research Access | Research Access |
| Estimated EPS (Low) | 1.610 | Research Access | Research Access | Research Access | Research Access |
| Number of Analysts (Estimated Revenue) | 1 | Research Access | Research Access | Research Access | Research Access |
| Number of Analysts (Estimated EPS) | 1 | Research Access | Research Access | Research Access | Research Access |
Log in to continue
Log in and subscribe to Full Access to see up to 5 years of analyst estimates.
Login — it's free(* All numbers are in thousands)
Current Key Metrics
Log in to continue
Log in to see all key valuation metrics and ratios for this symbol.
Login — it's freeForward P/E Ratios
Log in to continue
Log in with Full Access for forward P/E high/low estimates and the full multi-year table.
Login — it's freeSWOT Analysis
Strengths (preview)
- Established positioning in high-growth semiconductor test markets for silicon carbide, gallium nitride, and silicon photonics, directly aligned with industry expansion toward a $1 trillion scale by 2030.
- Reported Q3 FY2024 revenue of $7 million provides a baseline for monitoring sequential growth in specialized test systems amid sector tailwinds.
Log in with Research Access for Weaknesses, Opportunities, Threats, and the complete SWOT.
At what price to buy it? -
Intrinsic Value Calculator
Based on current fundamentals and analyst forecasts, MARKETSnap estimates AEHR intrinsic value between $0.47 – $0.50 per share. This depends on revenue growth, margins, and discount rate.
This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.
[intrinsic_calculator]
Common questions about AEHR valuation
Is Aehr Test Systems (AEHR) overvalued or undervalued right now?
MARKETSnap estimates intrinsic value for Aehr Test Systems (AEHR) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.
Is AEHR a buy, hold, or sell for long-term investors?
MARKETSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether AEHR trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.
What is AEHR’s P/E ratio?
You can see AEHR’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.
How is intrinsic value calculated for AEHR?
MARKETSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MARKETSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.
Is AEHR a good long-term investment?
Whether AEHR fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MARKETSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.
AEHR
1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.
Daily snapshot
3.25
Trading Metrics:
| Open: | 92.02 | Previous Close: | 90.55 | |
| Day Low: | 87.15 | Day High: | 93.81 | |
| Year Low: | 18.7 | Year High: | 147.4 | |
| Price Avg 50: | 92.23 | Price Avg 200: | 65.47 | |
| Volume: | 2.006M | Average Volume: | 2.594M |
Log in to continue
Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.
Login — it's free
